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Abstract: Inflammatory bowel diseases (IBDs) are chronic and relapsing immune disorders that
result, or possibly originate, from epithelial barrier defects. Intestinal organoids are a new reliable
tool to investigate epithelial response in models of chronic inflammation. We produced organoids
from the ulcerative colitis murine model Winnie to explore if the chronic inflammatory features
observed in the parental intestine were preserved by the organoids. Furthermore, we investigated if
quercetin administration to in vitro cultured organoids could suppress LPS-induced inflammation in
wild-type organoids (WT-organoids) and spontaneous inflammation in ulcerative colitis organoids
(UC-organoids). Our data demonstrate that small intestinal organoids obtained from Winnie mice
retain the chronic intestinal inflammatory features characteristic of the parental tissue. Quercetin
administration was able to suppress inflammation both in UC-organoids and in LPS-treated
WT-organoids. Altogether, our data demonstrate that UC-organoids are a reliable experimental
system for investigating chronic intestinal inflammation and pharmacological responses.
Keywords: inflammatory bowel diseases; quercetin; small intestinal organoids
1. Introduction
Inflammatory bowel diseases (IBDs) are chronic and relapsing immune disorders that include
Crohn’s disease (CD) and ulcerative colitis (UC), which can be discriminated based on the site of
inflammation and the histological alterations in the gut wall. Although the exact IBD etiology is still
unknown, a combination of multiple host (genetic predisposition and cellular and immune changes)
and environmental (e.g., diet, smoking, and chronic stress) factors has been proposed [1]. Increasing
evidence demonstrated that dysfunctions in the intestinal epithelium, a monolayer of cells that lies on
the lamina propria, play a crucial role in IBD pathogenesis [2].
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The most common experimental approaches to investigate IBD pathogenesis and/or to evaluate
their therapeutic options have been animal models and traditional two-dimensional (2-D) in vitro
cell cultures, using cell lines. The ethical issues of performing in vivo animal experiments, as well
as the less biologically relevant use of immortalized or transformed cell lines, paved the way for the
development of alternative experimental systems [3].
Gut organoids are three-dimensional (3-D) in vitro models of the gut epithelium that can be isolated
and grown from adult mucosal tissues (intestinal crypts) or by differentiation of embryonic (ESCs) or
induced pluripotent stem cells (iPSC). These “mini-intestines” display a typical polarized intestinal
epithelium subdivided in villus-like zones and crypt-like domains (“buds”). Indeed, in vitro intestinal
organoids are composed of similar differentiated epithelial phenotypes and relative proportions that
are present in the parental gut [4]. Interestingly, mini-intestines recapitulating the complex architecture
of in vivo gut epithelium have offered the opportunity to study physiological conditions (intestinal
development, nutrient and/or drug absorption, etc.) and pathological disorders, including IBDs and
cystic fibrosis [3,5,6].
Our laboratory obtained a spontaneous, progressive model of UC (Winnie). These mice are
characterized by a point mutation in the Muc2 gene that results in an unresolved endoplasmic reticulum
stress and consequent chronic intestinal inflammation [7]. The Winnie model could be particularly
relevant for exploring UC prevention strategies due to the slow progression toward the UC phenotype.
We recently demonstrated the potential for using nutritionally derived polyphenols as an adjuvant
for IBD treatment through regulation of immune cells and their secretion of inflammatory mediators [8].
Quercetin is a plant-derived polyphenolic compound belonging to the flavonols (a subclass of
flavonoids) and has shown beneficial effects in the prevention and/or treatment of several pathological
conditions, due to its anti-inflammatory, antioxidant, and antitumoral activities [9,10]. Our previous
studies showed that quercetin reduced the secretion of several inflammatory cytokines, including TNF-α,
from murine bone-marrow-derived dendritic cells (BMDCs) [11]. We also demonstrated that
the molecular mechanism was secretory leukoprotease inhibitor (Slpi)-dependent and involved
extracellular iron transport [12–14].
In this study, we used 3-D intestinal organoids obtained from wild-type (WT) or Winnie mice
(UC-organoids) to determine intestinal epithelial responses in a quercetin-enriched environment.
Organoids obtained from WT and Winnie mice respond to quercetin by suppressing the expression
of TNF-α, CCAAT/enhancer binding protein β (C/EBP-β), and lipocalin-2 (Lcn-2) and upregulating
Slpi, heme oxygenase 1 (Hmox1), and ferroportin 1 (Fpn1). Remarkably, we detected proliferative,
morphological, and molecular differences between our organoid populations. Indeed, UC-organoids
frequently showed a greater growth rate during subculture and displayed less organized structures,
together with an inflammatory profile. Overall, our findings suggest that the intestinal epithelium
responds to quercetin exposure by suppressing the inflammatory response. Furthermore, UC-organoids
representing a reliable tool that better resembles IBD inflammatory epithelium could be used for
various purposes (dietary investigations, therapeutic applications, etc.).
2. Results
2.1. Growth and Ultrastructural Comparison between WT- and UC-Organoids
In order to evaluate potential growth differences between WT- and UC-organoids, we measured
their surface area on day one and three for the initial three subpassages (P1–P3). On day one, both WT-
and UC-organoids were prevalently characterized by a rounded morphology. However, UC-organoids
were larger in respect to WT ones at P2 (4812 ± 184 vs. 3986 ± 198) and P3 (4140 ± 234 vs. 3018 ± 192)
(** p < 0.01 and *** p < 0.001, respectively). On day three, WT- and UC-organoids displayed a mature
morphology, but UC-organoids were significantly bigger than WT controls at P1 (43,269 ± 1879 vs.
31,974 ± 1732) (p < 0.01) (Figure 1A,B).
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 Figure 1. Proliferation of WT- and UC-organoids over time. (A) Representative images of WT- and
UC-organoids on day one and three, after seeding in Matrigel. Magnification 10×, scale bars 100 µm.
(B) Average surface area of organoids. Histograms represent mean surface area (µm2) ± SEM of
four independent experiments. Unpaired two-tailed Student’s t-test was used for statistical analysis.
*** p < 0.001, ** p < 0.01.
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In order to evaluate whether gut organoids obtained from Winnie mice resembled WT-organoids,
we compared the morphology and the ultrastructural organization of WT- and UC-organoids.
Light microscopy analysis showed WT-organoids displayed a characteristic rounded morphology,
with some buds or crypt domains extending outward and necrotic cells located in the central lumen
(Figure 2A). Enterocytes, characterized by the presence of the nucleus in the basal region, delimited the
organoid structure. Organoids grown from the small-intestinal crypts isolated from Winnie mice
exhibited an irregular morphology (Figure 2B). Enterocytes showed a more disorganized arrangement
and delimited a central lumen characterized by the presence of some necrotic cells (Figure 2B). In order
to better clarify the morphology of small-intestinal organoids, a comparison with small-intestine
biopsies isolated from WT and Winnie mice was performed. The WT small intestine showed the
presence of several intestinal villi in which enterocytes and Paneth cells were observed (Figure 2C).
A less-organized arrangement of small-intestinal villi was observed in Winnie mice, in which enterocytes
and Paneth cells were hardly distinguished (Figure 2D).
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Figure 2. (A) Light microscopy analysis of blue toluidine stained WT-organoids showing enterocytes
arranged in a round irregular monolayer and delimiting a central lumen in which some necrotic cells
were observed (white asterisk). Some buds, mimicking the intestinal crypts, extended from the organoid
(black arrow) (bar: 20 µm). (B) Light microscopy analysis of UC-organoids, showing enterocytes
arranged in n irregular multilayer structure (black arrows), surrounding a necrotic area (white
asterisk) (bar: 20 µm). (C) Small intesti e from WT mice, showing intestinal illi in longitudinal section.
Enterocytes (black arrow) and Paneth cells (white arrow) were observed (bar: 20µm). (D) Small intestine
from Winnie mice showing intestinal villi in longitudinal section. A less-organized morphology was
observed in which enterocytes (black arrow) and Paneth cells (white arrow) were hardly recognizable
(bar: 20 µm).
TEM analysis of WT-organoids showed the presence of enterocytes and Paneth cells organized
in round-shaped structures resembling intestinal villi in a transversal section (Figure 3A).
Enterocytes showed a polarized organization with basally located nuclei (Figure 3B). At higher
magnifications, several small microvilli extruding from the apical membrane of the cells were
distinguished (Figure 3C), and desmosomes on the lateral surfaces of enterocytes were observed
(Figure 3D). Organoids obtained from Winnie intestines showed a round-shaped organization in which
enterocytes and Paneth cells were observed (Figure 3E). At higher magnification, Paneth cells showed
several cytoplasmic granules (Figure 3F), while enterocytes showed some cytoplasmic vacuoles and
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dilated rough endoplasmic reticulum (RER) (Figure 3F,G). A reduced amount and shorter microvilli
were observed on the apical surface of the cells (Insert in Figure 3F). Compared to organoids obtained
from WT, enterocytes of UC-organoids were loosely connected to each other, as frequent white areas
were observed by TEM (Figure 3E). Despite this, no difference in desmosomes was revealed between
WT- and UC-organoids (Figure 3D,H).
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Figure 3. (A) TEM image of organoids obt i fro WT intestinal crypts. Enterocytes (e) were
organized in a round structure delimiti tral lumen (L), r sembling an intestinal v llus in
transver al ection (bar: 10 µm). (B) E t r tes (e) showing a polarized organization, with nuclei
located close to the basal side of the cell and several microvilli at the apical surface (black arrow).
Paneth cells (p) were observed (bar: 500 nm). (C) Detail of microvilli on the apical surface of the
enterocytes (e) (bar: 2000 nm). (D) Desmosomes on the lateral surface of enterocytes were detected
(white arrows) (bar: 500 nm). (E) TEM analysis of organoids obtained from Winnie intestinal crypts
(bar: 20 µm). (F) Paneth cells (p), characterized by the presence of several granules and enterocytes
(e), were observed (bar: 5 µm). On the apical surface of enterocytes, short microvilli were detected
(insert; bar: 200 nm). (G) Detail of an enterocyte, showing a dilated RER (white arrows) (bar: 200 nm).
(H) Desmosomes on the lateral surface of enterocytes were detected (bar: 500 nm).
To determine whether in vitro gut organoids resemble the in vivo intestinal epithelium in WT
and Winnie mice, we next compared their ultrastructure. The intestinal wall of WT mice showed
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several villi in transversal sections (Figure 4A) in which enterocytes, Paneth cells, and goblet cells were
distinguished (Figure 4B,C). Enterocytes showed several microvilli on their apical surface (Figure 4C)
and desmosome junctions on the lateral surfaces (Figure 4D); moreover, well-preserved organelles,
such as mitochondria, RER, and Golgi complex, were observed. TEM analysis of Winnie intestinal
biopsies showed several villi in transversal sections, in which enterocytes and distended cells with
vacuolar material were visible (Figure 4E,F). At higher magnification, distended cells showed abundant
cytoplasmic vacuoles (Figure 4G), whilst enterocytes were characterized by the presence of several
dilated RER, enlarged Golgi complex (Figure 4H), and mitochondria with enlarged cristae (Figure 4H).Int. J. Mol. Sci. 2019, 20, x 7 of 16 
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2.2. Comparison of Endogenous Gene Expression of WT- and UC-Organoids  
We next compared the molecular expression of selected genes in WT- and UC-organoids. A 
significant upregulation of TNF-α was detected in UC-organoids, which was in line with what was 
observed in the parental tissue (** p < 0.01). Similarly, Slpi and Lcn-2 were upregulated (* p < 0.05 and 
Figure 4. (A) TEM analysis of intestinal biop isolated from WT mice. Villi in transversal sections
(bar: 20 µm). (B) Transversal sectio of an intestinal villus. Paneth cells (p) were observed (bar:
20 µm). (C) Goblet cells (g) and enterocytes (e) with basally located nuclei and microvilli (black arrows)
on the apical surface of the cells were observed (bar: white arrows) (bar: 500 nm). (D) Detail of
microvilli on the apical surface of enterocytes (white arrows) and desmosomes on the lateral surface of
enterocytes (arrowheads) (bar: 500 nm). (E) TEM analysis of intestinal biopsies isolated from Winnie
mice. Transversal section of intestinal villi (bar: 20 µm). (F) Detail of an intestinal villus in which
enterocytes (e) nd distended cell were observed (bar: 20 µm). (G) Distended c ll containi g several
vacuoles (black arrows) (bar: 2000 nm). (H) Enterocyte showing a preserved nucleus (n), dilated RER
(white arrows), several mitochondria (m), and enlarged Golgi complex (black arrow) (bar: 2000 nm).
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2.2. Comparison of Endogenous Gene Expression of WT- and UC-Organoids
We next compared the molecular expression of selected genes in WT- and UC-organoids.
A significant upregulation of TNF-α was detected in UC-organoids, which was in line with what was
observed in the parental tissue (** p < 0.01). Similarly, Slpi and Lcn-2 were upregulated (* p < 0.05
and ** p < 0.01, respectively), while C/EBP-β (** p < 0.01), Hmox1, and Fpn1 (*** p < 0.001) were
downregulated (Figure 5).
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2.3. Effect of Quercetin on WT Intestinal Organoids
To evaluate the organoid response to the inflammatory stimulus (LPS), organoids from WT small
intestines were cultured in the presence of 1µM LPS and the mRNA collected 6 h later. We used the
same quercetin concentration of our previous studies focused on DCs [11–14]. TNF-α expression was
significantly increased in LPS-treated organoids compared to control (*** p < 0.001). Quercetin treatment
significantly reduced the LPS-induced TNF-α expression (* p < 0.05) (Figure 6A).
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of selected genes was calculated relative to untreated WT-organoids (control). Histograms represent
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used for statistical analysis. *** p < 0.001, ** p < 0.01, * p < 0.05.
Due to the crucial role of Slpi expression in suppressing LPS-induced inflammation in
BMDCs [12,13], we investigated whether quercetin affected Slpi induction. Quercetin exposure
promoted Slpi expression (p < 0.01) in WT-organoids. Organoids treated with LPS also upregulated
Slpi (** p < 0.01), but the induction was significantly higher if the organoids were pretreated with
quercetin (* p < 0.05) (Figure 6B). A similar pattern of expression was detected for C/EBP-β. Indeed,
C/EBP-β mRNA expression was higher in LPS-treated WT-organoids (* p < 0.01) compared to control,
and with quercetin downregulating this effect (* p < 0.05) (Figure 6C).
Lcn-2, which was highly expressed in LPS-treated organoids (** p < 0.01), showed a slight increase
when WT organoids were exposed to quercetin in the presence of LPS (Figure 6D).
Based on our previous results demonstrating the effects of quercetin on iron homeostasis in
BMDCs [14], we assessed the expression of Hmox1 and Fpn1 mRNA. Interestingly, we found a
significant increase of Hmox1 and Fpn1 expression in WT-organoids exposed to quercetin in the
presence of LPS (*** p < 0.001 and ** p < 0.01, respectively) (Figure 6E,F). Fpn1 was downregulated in
LPS-treated organoids (** p < 0.01).
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2.4. Effect of Quercetin on Winnie Intestinal Organoids
As previously demonstrated with Winnie mice, Slpi, Hmox1, and TNFα intestinal expression is
regulated by a quercetin-enriched diet [15]. Quercetin treatment of UC-organoids caused a significant
decrease of the inflammatory-related genes TNFα, C/EBP-β and Lcn-2 (*** p < 0.001, * p < 0.05 and
** p < 0.01, respectively), conversely genes associated with inflammatory suppression and tissue repair
(Slpi, Hmox1, and Fpn1) were induced by quercetin exposure (*** p < 0.001) (Figure 7). Of note,
genes related with epithelial permeability (tight junction protein Cldn-1, Cldn-2, Cldn-4, and Ocln) did
not change in response to quercetin exposure in UC-organoids.
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3. Discu sion
The gut epithelial cell barrier is a remarkable defense system that acts as a physical,
chemical, and electrical barrier [16]. This crucial function relies on several different strategies,
including tight junctions that regulate the paracellular permeability, a mucus layer covering the lu inal
Int. J. Mol. Sci. 2019, 20, 5771 10 of 15
epithelial surface, and antimicrobial peptide secretion, which provides primary protection against
microorganisms [17]. Intestinal barrier function depends upon specialized cell types (absorptive
enterocytes, goblet cells, enteroendocrine cells, Paneth cells, and tuft cells) that originate from epithelial
stem cells located within the base of the intestinal crypts [18]. It is well-known that failure of gut
barrier function contributes to IBD pathogenesis and permits the intestinal microbiota to contact the
underlying immune cells in the lamina propria, causing an immune response [2,19].
Recent discovery of intestinal adult stem cells and, consequently, the development of procedures
to generate intestinal organoids have provided an innovative 3-D model that could replace
traditional experimental systems (i.e., 2-D cell lines and in vivo models). Organoids could become
the most important experimental system for various applications, including gut-disease modelling,
intestinal organogenesis, host–pathogen interactions, regenerative medicine, etc. [3,5,6].
In this study, we treated gut organoids with quercetin to evaluate the contribution of gut
epithelial cells to the inflammatory suppression we previously observed following polyphenol oral
administration to mice (insert the reference). First, we compared WT gut organoids and organoids
from the Winnie mouse, a murine model of spontaneous UC that could better mimic IBD [7]. In vitro
Winnie organoids displayed similar morphology to WT the day after seeding, and both exhibited
villi and crypt-like domains following several passages. Specialized cell types such as enterocytes
and Paneth cells were present in WT- and UC-organoids and distributed as in the in vivo setting.
Remarkably, although cell-to-cell interactions, such as desmosomes, were preserved in WT- and Winnie
organoids, the UC-organoids appeared less organized than WT mini-guts. Notably, the average area of
UC-organoids was larger than WT controls, possibly because of the inflammatory microenvironmental
milieu. Following inflammatory LPS-stimulation, gut organoids upregulated inflammatory mediators,
such as TNF-α and LCN-2. LCN-2 is also known as neutrophil gelatinase-associated lipocalin (NGAL)
and is highly expressed by intestinal epithelial cells in inflammatory disorders, including in IBD [20].
The anti-inflammatory activity of LCN-2 is due to its capacity to sequestrate iron, limiting the bacterial
growth and blocking gut dysbiosis during intestinal inflammation [20]. LCN-2 expression is also
linked to TNF-α production; indeed, a previous study on human colonic cell lines demonstrated that
LCN-2 is regulated by TNF-α and other Th17 cytokines (i.e., IL-17A and IL-22) [21].
Strikingly, quercetin suppressed these inflammatory genes induced by LPS, decreasing the
expression levels of both TNF-α and LCN-2 mRNA. As previously observed in BMDCs [12,13],
we found that quercetin was able to upregulate Slpi expression in WT-organoids. Slpi is a key
serine proteinase inhibitor, with potent antimicrobial activity that is mostly produced by immune cell
types (i.e., DCs, neutrophils and macrophages) [22]. However, Slpi production by human intestinal
epithelium has been demonstrated by Si-Tahar et al. and suggests its protective role against harmful
attacks of microbes, digestive enzymes, and inflammatory cells [23].
Notably, the anti-inflammatory effect of quercetin was also coupled with a reduced expression
of C/EBP-β, a transcription factor that triggers the expression of various inflammatory mediators,
including TNF-α [24]. Gut epithelial reduction in C/EBP-β expression and consequent inhibition of the
inflammatory response following quercetin administration is consistent with earlier reports on both
epithelial cell lines [25,26] and BMDCs [27].
We previously observed that the anti-inflammatory ability of quercetin was strictly associated with
iron-sequestration in the extracellular milieu. Quercetin supplementation in the BMDCs culture media
affected DCs’ iron metabolism, inducing the upregulation of Hmox, a cytosolic enzyme that produced
ferrous irons, and Fpn1, which allows iron extracellular export [14]. In line with these data, in this study,
we found that quercetin exposure upregulated Hmox and Fpn1 mRNA expression, even in the absence
of LPS administration. Our results are in contrast with Lesjak M. et al., who reported a significant
decrease in Fpn1 mRNA expression in the intestinal cell line (Caco2) exposed to quercetin [28], but this
discrepancy may be due to a different experimental protocol and the use of primary epithelial cells
versus a Caco2 cell line.
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Interestingly, UC-organoids shared a similar inflammatory profile to that of LPS-treated
WT-organoids, as revealed by the upregulation of TNF-α, LCN-2 and Slpi mRNA. It was expected
that LCN-2 and Slpi expression would be higher in UC-organoids, as Heazlewood et al., who first
described the Winnie model, found their increased expression in the intestinal tissues of these mice [7].
Furthermore, we have already demonstrated that inflamed colonic tissues expressed Slpi as a likely
anti-inflammatory protective mechanism [11]. As far as the iron metabolism is concerned, we found
a molecular pattern similar to that of WT mini-gut LPS-stimulated with a superimposable Hmox
expression level and the downregulation of Fpn1. Surprisingly, C/EBP-β mRNA expression was
downregulated in UC-organoids. Nonetheless, C/EBP-β expression level decreased in quercetin-treated
UC-organoids. In line with our previous study on Winnie mice fed with a polyphenol-enriched
diet [15], here we found that the presence of quercetin was able to dampen the inflammatory profile of
UC-organoids, as demonstrated by the downregulation of both TNF-α and LCN-2 mRNA and the
induction of inflammatory suppressors (i.e., Slpi, Hmox1, and Fpn1). Taken together, these data show
that the Winnie organoid model mirrors the inflammatory status of the epithelium during inflammation,
similar to that of LPS, and that quercetin can modulate inflammatory responses in both settings.
Intestinal organoids have already been used as 3-D models for nutritional studies, in order to
evaluate the effects of various dietary nutrients and polyphenolic compounds on the intestinal growth
and development [29,30]. Currently, the impact of quercetin on intestinal epithelium functions has been
tested in vitro, using human colonic epithelial cell line Caco-2 [31–33] and self-renewing monolayers
of primary colonic or rectal epithelial cells [34]. Hence, to the best of our knowledge, this is the
first study that used 3-D gut organoids to demonstrate the anti-inflammatory effects of quercetin
on intestinal epithelial cells and, consequently, its beneficial role on gut health. We recognize that
results could become more relevant when confirmed by using human organoids from UC patients
and healthy controls; nonetheless, the present study represents an important experimental setup.
Future studies will be able to take advantage of the results described in the present study, in order to
evaluate the efficiency of new pharmacological interventions for chronic inflammatory syndromes of
the gastrointestinal tract.
4. Materials and Methods
4.1. Ethics Statement
Our experiments were conducted in agreement with national and international guidelines and
were approved by the authors’ institutional review board (Organism for Animal Well-Being—OPBA).
All animal experiments were carried out in accordance with Directive 86/609 EEC, enforced by Italian
D.L. n. 116/1992, and approved by the Committee on the Ethics of Animal Experiments of Ministero
della Salute–Direzione Generale Sanità Animale (Prot. 768/2015-PR 27/07/2015) and the official RBM
veterinarian. Animals were sacrificed if found to be in a severe clinical condition, in order to avoid
undue suffering.
4.2. Isolation of Mouse Small-Intestinal Crypts and Organoid Culture
Intestinal crypts were isolated from the small intestine of 4 wild-type mice purchased from
Jackson Laboratories (C57BL/6, Stock No.: 000664) or from 4 Winnie mice obtained from the University
of Tasmania, according to the protocol suggested by Stemcell Technologies Inc. After harvesting,
the small intestine was flushed with cold Dulbecco’s phosphate buffered saline (DPBS) (Gibco, Waltham,
MA, USA), in a petri dish, and cut longitudinally. The resulting intestinal sheet was washed several
times with cold DPBS and then minced into 2 mm fragments. After being transferred into a 50 mL conical
tube, tissue pieces were washed several times until the supernatant was clear. Next, intestinal fragments
were incubated with Gentle Cell Dissociation Reagent (GCDR) (Stemcell Technologies Inc., Vancouver,
Canada), at room temperature, for 15 min, on a rocking platform. To detach the intestinal crypts
from the basal membrane, GCDR was replaced with cold DPBS + 0.1% bovine serum albumin (BSA)
Int. J. Mol. Sci. 2019, 20, 5771 12 of 15
(Sigma-Aldrich, St. Louis, MO, USA), and a mechanical force (pipetting) was imposed. Crypt-enriched
supernatants were filtered through a 70 µm cell strainer (Corning, NY, USA) in a new 50 mL conical
tube. The pipetting/filtration procedure was repeated four times, and then the fractions containing
abundant amounts of intestinal crypts were selected for culturing and centrifuged at 200× g, for 5 min,
to eliminate single-cell contamination.
After counting with an inverted microscope, the isolated intestinal crypts were re-suspended in
room-temperature IntestiCult™ Organoid Growth Medium (Stemcell Technologies Inc., Vancouver,
Canada) and mixed 1:1 with ice-cold Matrigel Matrix (Corning, NY, USA). For organoid generation,
intestinal crypts were plated in 24-well tissue culture plates (Corning, NY, USA) (200 crypts per 50 µL
per well) and maintained at 37 ◦C, for 10 min, to allow Matrigel domes to polymerize. Next, 750 µL of
room-temperature IntestiCult™ Organoid Growth Medium was added to each well, and the plates
were further incubated at 37 ◦C and 5% CO2. The culture media were changed three times per week.
Intestinal organoids were split when they showed dark necrotic cores and used for experiments,
starting from the third passage.
4.3. Organoid Growth Assessment
To evaluate WT- and UC-organoid growth during their subculture, intestinal crypts were seeded
in 24-well tissue culture plates (100 crypts per 50 µL per well) and cultured for 3 days, as described
above. Representative images of intestinal organoids were acquired at 1 and 3 days after seeding,
using the inverted microscope Eclipse Ti2 (Nikon Instruments, Amsterdam, Netherlands), and the
surface area of organoids (µm2) was measured in the horizontal direction, with ImageJ Software
(National Institute of Health, Bethesda, MD, USA) [35].
4.4. TEM Analysis
Intestinal organoids, obtained as previously described, and fragments of intestinal sheets,
isolated from the small intestine of WT and Winnie mice, were briefly washed in DPBS and then
immediately fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 24 h, at 4 ◦C. After several
washes in 0.15 M cacodylate buffer, all the samples were post-fixed in 1% OsO4, in cacodylate buffer
0.1 M, for 1 h, at room temperature, gradually dehydrated by graded acetone serial steps and embedded
in epoxy resin. Ultrathin slices of 100 nm were stained by uranyl acetate solution and lead citrate,
and then observed with transmission electron microscope CM10 Philips (FEI Company, Eindhoven,
The Netherlands), at an accelerating voltage of 80 kV. Images were recorded by a Megaview III
digital camera (FEI Company, Eindhoven, The Netherlands). Sections of 300 nm were stained with
1% toluidine blue solution and were observed by the light microscope Nikon Eclipse E800 (Nikon,
Tokyo, Japan).
4.5. Small-Intestinal Crypt Stimulation
Intestinal crypts were seeded in 24-well tissue culture plates (Corning, NY, USA) (100 crypts
per 50 µL per well) and maintained at 37 ◦C and 5% CO2, until the appearance of mature organoids
(4 days after seeding). Organoid maturation was monitored daily with the inverted microscope Eclipse
Ti2 (Nikon Instruments, Amsterdam, Netherlands). Intestinal organoids were incubated with 25 µM
of quercetin (Sigma-Aldrich, St Louis, MO, USA). After 4 h, intestinal organoids were stimulated
with 1 µg/mL of LPS (L6143, Sigma-Aldrich, St Louis, MO, USA) for 6 h. Mature organoids that did
not receive quercetin treatment or LPS stimulation were used as controls for comparative analyses.
All experiments were performed in triplicate.
4.6. RNA Extraction and qPCR Analysis
Total RNA was isolated from small-intestinal organoids by using TRIzol® (Thermo Fisher Scientific,
MA, USA) reagent method, according to manufacturer’s instructions. Then, 1 µg of total RNA was
retrotranscribed with the iScript cDNA Synthesis kit (Biorad, CA, USA), using random primers
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for cDNA synthesis. The expression of TNF-α, Hmox1, Fpn1, Slpi, and Gapdh was assessed with
TaqMan gene-expression assay (Thermo Fisher Scientific, MA, USA) murine probes: Mm00443258_m1,
Mm00516005_m1, Mm01254822_m1, Mm00441530_g1, and Mm99999915_g1, respectively. For C/EBP-β,
qRT-PCR reactions were performed by using SYBR Green chemistry with QuantiTect Primer Assay
(Qiagen, Hilden, Germany) and SsoAdvanced Universal SYBR Green Supermix (BioRad Laboratories,
Hercules, CA, USA). All qPCR assays were executed on a CFX96 System (Biorad, CA, USA). For the
relative expression, the results were examined with the ∆∆Ct method, considering Gapdh as the
internal reference gene.
4.7. Statistical Analysis
Statistical analysis was performed by using the GraphPad Prism statistical software release 5.0 for
Windows XP. All data were expressed as mean ± SEM. The statistical significance was determined with
the two-tailed Student’s t-test. Results were considered statistically significant at p < 0.05. Experiments
were carried out at least three times.
5. Conclusions
The in vitro Winnie gut organoid model mimics the in vivo disease setting demonstrating
characteristic inflammatory gene regulation of TNF-α, Slpi and Lcn-2. Quercetin regulates epithelial
inflammatory genes involved in both the LPS-induced organoid and the Winnie organoid models of
inflammation downregulating Lcn-2, TNF-α and C/EBP-β and upregulating Hmox1 and Fpn1.
Winnie gut organoids show a similar morphology to WT-organoids and are a useful model to
study gut epithelial inflammatory responses.
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Abbreviations
IBD Inflammatory bowel disease
CD Crohn’s disease
UC Ulcerative colitis
2-D Two-dimensional
3-D Three-dimensional
ESCs Embryonic stem cells
iPSCs Induced pluripotent stem cells
BMDCs Bone marrow dendritic cells
Slpi Secretory leukoprotease inhibitor
WT Wild-type
Hmox1 Heme oxygenase 1
Fpn1 Ferroportin-1
C/EBP-β CCAAT/enhancer binding protein β
Lcn-2 Lipocalin2
DPBS Dulbecco’s phosphate buffered saline
GCDR Gentle cell dissociation reagent
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